<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365494">
  <stage>Registered</stage>
  <submitdate>16/12/2013</submitdate>
  <approvaldate>9/01/2014</approvaldate>
  <actrnumber>ACTRN12614000023651</actrnumber>
  <trial_identification>
    <studytitle>genetic alteration in preeclampsia</studytitle>
    <scientifictitle>Impact of genetic polymorphism on the development of preeclampsia and its severity </scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>603/26  faculty of medicine Alexandria university </secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>preeclampsia </healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fertility including in vitro fertilisation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A prospective case control study
 Will include 120 preeclamptic patients will be  subdivided into mild and severe groups according to blood pressure and proteinuria .2 ml venous blood samples were taken once from the patient under a septic technique   on Vaccutainer Ethylenediaminetetraacetic acid (EDTA)  tubes . Deoxyribonucleic acid (DNA)   Extraction and Purification using a DNA salting-out technique.Detection of C677T MTHFR gene polymorphis ,G1691A Factor V Lieden , G20210A Prothrombin genes and insertion /deletion(I/D) of ACE  polymorphisms were done.
</interventions>
    <comparator>120 age-matched normotensive pregnant females
2 ml venous blood samples were taken under a septic technique   on Vaccutainer EDTA tubes . DNA   Extraction and Purification using a DNA salting-out technique.Detection of C677T MTHFR gene polymorphis ,G1691A Factor V Lieden , G20210A Prothrombin genes and insertion /deletion(I/D) ofACE  polymorphisms were done.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome> The correlation of the development of preeclampsia and the levels of methylene Tetrahydrofolate reductase (MTHFR), Factor five (FV Lieden), Prothrombin genes polymorphisms and angiotensin converting enzyme (ACE) polymorphism measured</outcome>
      <timepoint>after analysis of the genetic study of the blood sample </timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>The correlation of the severity of preeclampsia and the levels of methylene Tetrahydrofolate reductase (MTHFR), Factor five (FV Lieden), Prothrombin genes polymorphisms and angiotensin converting enzyme (ACE) polymorphism measured</outcome>
      <timepoint>after analysis of the genetic study of the blood sample </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>none</outcome>
      <timepoint>none</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>normotensive pregnant female in third trimester 
mild preeclampsia in third trimester 
severe preeclampsia in third trimester </inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>38</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>other hypertensive diseases with pregnancy </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Case control</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/01/2014</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>17/04/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>240</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>alexandria</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>alexandria university , faculty of medicine</primarysponsorname>
    <primarysponsoraddress>22 elgeish street , elshatby 21526
Alexandria , egypt</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress> Elshatby maternity university Hospital
port saeed street 
alexandria ,Egypt 
 21526</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>study of the effect of the presence of gene mutation on development of preeclampsia and determination of its severity </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>ethical committe , faculty of medicine ,alexandria university</ethicname>
      <ethicaddress>Champollion Street

El-Khartoum Square

Azarita Medical Campus alexandria egypt 
 21526</ethicaddress>
      <ethicapprovaldate>27/11/2013</ethicapprovaldate>
      <hrec>IRB  00007555-fwa no : 00015712</hrec>
      <ethicsubmitdate />
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>ahmed fawzy galal</name>
      <address>Elshatby maternity university hospital 
port saeed street
 alexandria Egypt
 21526</address>
      <phone>+201222286962</phone>
      <fax />
      <email>galal_af@yahoo.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>ahmed fawzy galal</name>
      <address>Elshatby maternity university hospital 
port saeed street 
alexandria Egypt
 21526</address>
      <phone>+201222286962</phone>
      <fax />
      <email>galal_af@yahoo.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>ahmed fawzy galal</name>
      <address>Elshatby maternity university hospital
 port saeed street 
alexandria Egypt
 21526</address>
      <phone>+201222286962</phone>
      <fax />
      <email>galal_af@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>ahmed fawzy galal</name>
      <address>Elshatby maternity university hospital
 port saeed street 
alexandria Egypt
 21526</address>
      <phone>+201222286962</phone>
      <fax />
      <email>galal_af@yahoo.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>